American Renal Associates Holdings (American Renal Associates Holdings) ROCE % : 9.93% (As of Sep. 2020)

View and export this data going back to 2016. Start your Free Trial

What is American Renal Associates Holdings ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. American Renal Associates Holdings's annualized ROCE % for the quarter that ended in Sep. 2020 was 9.93%.

American Renal Associates Holdings ROCE % Historical Data

The historical data trend for American Renal Associates Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

American Renal Associates Holdings ROCE % Chart

American Renal Associates Holdings Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

ROCE %

Get a 7-Day Free Trial

18.38

16.60

11.69

7.27

6.19

American Renal Associates Holdings Quarterly Data
	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20
ROCE %	Get a 7-Day Free Trial															7.95	5.38	2.18	11.97	9.93

American Renal Associates Holdings ROCE % Calculation

American Renal Associates Holdings's annualized ROCE % for the fiscal year that ended in Dec. 2019 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2019 )		(A: Dec. 2018 )		(A: Dec. 2019 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2019 )		(A: Dec. 2018 )		(A: Dec. 2019 )
	=	51.894	/	( ( (985.843 - 201.34)	+	(1086.791 - 193.935) )	/ 2 )
	=	51.894	/	( (784.503	+	892.856)	/ 2 )
	=	51.894	/	838.6795
	=	6.19 %

American Renal Associates Holdings's ROCE % of for the quarter that ended in Sep. 2020 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2020 )		(Q: Jun. 2020 )		(Q: Sep. 2020 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2020 )		(Q: Jun. 2020 )		(Q: Sep. 2020 )
	=	88.608	/	( ( (1199.699 - 322.221)	+	(1160.201 - 252.693) )	/ 2 )
	=	88.608	/	( ( 877.478	+	907.508 )	/ 2 )
	=	88.608	/	892.493
	=	9.93 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2020) EBIT data.

American Renal Associates Holdings (NYSE:ARA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

American Renal Associates Holdings ROCE % Related Terms

Thank you for viewing the detailed overview of American Renal Associates Holdings's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

American Renal Associates Holdings (American Renal Associates Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » American Renal Associates Holdings Inc (NYSE:ARA) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

500 Cummings Center, Suite 6550, Beverly, MA, USA, 01915

Website

https://www.americanrenal.com

American Renal Associates Holdings Inc is a joint venture-focused dialysis services provider in the United States. The company through its subsidiary is engaged in providing kidney dialysis services for patients suffering from chronic kidney failure, also known as end-stage renal disease. It also offers outpatient and inpatient dialysis treatments for patients suffering from chronic kidney failure.

Executives

Don E Williamson	officer: EVP, Chief Operating Officer	500 CUMMINGS CENTER, SUITE 6550 BEVERLY MA 01915
Victoria Labriola	officer: VP and General Counsel	AMERICAN RENAL HOLDINGS, INC. 500 CUMMINGS CENTER, SUITE 6550 BEVERLY MA 01915
Joseph A Carlucci	director, officer: Chief Executive Officer	C/O AMERICAN RENAL ASSOCIATES HOLDINGS 500 CUMMINGS CENTER BEVERLY MA 01915
Syed T Kamal	director, officer: President	C/O AMERICAN RENAL ASSOCIATES HOLDINGS 500 CUMMINGS CENTER BEVERLY MA 01915
Jeremy Gelber	director	C/O CENTERBRIDGE PARTNERS, L.P., 375 PARK AVE, 12TH FLOOR, NEW YORK NY 10152
Christopher J Hocevar	director	1601 CHESTNUT STREET SHAREHOLDER SERVICES TL05Y PHILADELPHIA PA 19192
Robert H Fish	director	C/O SKILLED HEALTHCARE 27442 PORTOLA PARKWAY, SUITE 200 FOOTHILL RANCH CA 92610
Michael Boxer	director	9151 BOULEVARD 26 NORTH RICHLAND HILLS TX 76180
John M Jureller	director	FRONTIER COMMUNICATIONS, 401 MERRITT 7, NORWALK CT 06851
Thomas W Erickson	director	OMEGA HEALTHCARE INVESTORS INC, 900 VICTORS WAY STE. 350, AMM ARBER MI 48108
Jason Boucher	officer: Former VP & CFO	500 CUMMINGS CENTER SUITE 6550 BEVERLY MA 01915
Mark Herbers	officer: Interim CFO and Interim CAO	500 CUMMINGS CENTER, SUITE 6550, BEVERLY MA 01915
Michael Ray Costa	officer: VP and General Counsel	C/O AMERICAN RENAL ASSOCIATES HOLDINGS 500 CUMMINGS CENTER BEVERLY MA 01915
Patrick T Ryan	director	401 EDGEWATER PLACE, SUITE 500, WAKEFIELD MA 01880
Jonathan L Wilcox	officer: VP & Chief Financial Officer	C/O AMERICAN RENAL ASSOCIATES HOLDINGS 500 CUMMINGS CENTER BEVERLY MA 01915